Telomerase activity in human solid tumors: Diagnostic utility and clinical applications

American Journal of Clinical Pathology

Volumn 112, Issue 1 SUPPL. 1, 1999, Pages

  Vasef, Mohammad A ^a,d   Ross, Jeffrey S ^c   Cohen, Michael B ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c ALBANY MEDICAL COLLEGE   (United States)

^d UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

Cancer; In situ hybridization; Polymerase chain reaction; Telomerase

Indexed keywords

DNA; DNA POLYMERASE; MESSENGER RNA; TELOMERASE; TUMOR MARKER;

BREAST CARCINOMA; ENZYME ACTIVITY; FEMALE GENITAL TRACT TUMOR; HEAD AND NECK CARCINOMA; HUMAN; KIDNEY CARCINOMA; MINIMAL RESIDUAL DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CARCINOMA; RECURRENT CANCER; REVIEW; SOLID TUMOR; TELOMERE; UROGENITAL TRACT TUMOR;

HUMANS; NEOPLASMS; POLYMERASE CHAIN REACTION; PROGNOSIS; TELOMERASE;

EID: 0033493173     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (101)

1. Zakian VA. Structure and function of telomeres. Annu Rev Genet. 1989;23:579-604.
2. Blackburn EH. Structure and function of telomeres. Nature. 1991;350:569-573.
3. Greider CW, Blackburn EH. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell. 1985;43:405-413.
4. Greider CW, Blackburn EH. A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature. 1989;337:331-337.
5. Greider CW, Blackburn EH. The telomerase terminal transferase of Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity. Cell. 1987;51:887-898.
6. Harley CB, Villeponteau B. Telomeres and telomerase in aging and cancer. Curr Opin Genet Dev. 1995;5:249-255.
7. Morin GB. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell. 1989;59:521-529.
8. Allsopp RC, Vaziri H, Patterson C, et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci U S A. 1992;89:10114-10118.
9. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature. 1990;345:458-460.
10. Counter CM, Avilion AA, LeFeuvre CE, et al. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J. 1992;11:1921-1929.
11. Levy MZ, Allsopp RC, Futcher AB, et al. Telomere end-replication problem and cell aging. J Mol Biol. 1992;225:951-960.
12. Lee HW, Blasco MA, Gottlieb GJ, et al. Essential role of mouse telomerase in highly proliferative organs. Nature. 1998;392:569-574.
13. Olovnikov AM. A theory of marginotomy: the incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. J Theor Biol. 1973;41:181-190.
14. Meeker AK, Coffey DS. Telomerase: a promising marker of biological immortality of germ, stem, and cancer cells; a review. Biochemistry. 1997;62:1323-1331.
15. Zhu L, Hathcock KS, Hande P, et al. Telomere length regulation in mice is linked to a novel chromosome locus. Proc Natl Acad Sci U S A. 1998;95:8648-8653.
16. Feng J, Funk WD, Wang SS, et al. The RNA component of human telomerase. Science. 1995;269:1236-1241.
17. Blasco MA, Funk W, Villeponteau B, et al. Functional characterization and developmental regulation of mouse telomerase RNA. Science. 1995;269:1267-1270.
18. Avilion AA, Piatyszek MA, Gupta J, et al. Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res. 1996;56:645-650.
19. Harrington L, McPhail T, Mar V, et al. A mammalian telomerase-associated protein. Science. 1997;275:973-977.
20. Nakayama J, Saito M, Nakamura H, et al. TLP1: a gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family. Cell. 1997;88:875-884.
21. Counter CM, Meyerson M, Eaton EN. The catalytic subunit of yeast telomerase. Proc Natl Acad Sci U S A. 1997;94:9202-9207.
22. Lingner J, Hughes TR, Shevchenko A, et al. Reverse transcriptase motifs in the catalytic subunit of telomerase. Science. 1997;276:561-567.
23. Lendvay TS, Morris DK, Sah J, et al. Senescence mutants of Saccharomyces cerevisiae with a defect in telomere replication identify three additional EST genes. Genetics. 1996;144:1399-1412.
24. Meyerson M, Counter CM, Eaton EN, et al. hEST2, the putative human telomerase catalytic subunit gene, is upregulated in tumor cells and during immortalization. Cell. 1997;90:785-795.
25. Ramakrishnan S, Eppenberger U, Mueller H, et al. Expression profile of the putative catalytic subunit of the telomerase gene. Cancer Res. 1998;58:622-625.
26. Piatyszek MA, Kim NW, Weinrich SL, et al. Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol (TRAP). Meth Cell Sci. 1995;17:1-15.
27. Counter CM, Hirte HW, Bacchetti S, et al. Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci U S A. 1994;91:2900-2904.
28. Nilsson P, Mehle C, Remes K, et al. Telomerase activity in vivo in human malignant hematopoietic cells. Oncogene. 1994;9:3043-3048.
29. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science. 1994;266:2011-2015.
30. Wright WE, Shay JW, Piatyszek MA. Modifications of a telomeric repeat amplification protocol (TRAP) results in increased reliability, linearity and sensitivity. Nucl Acid Res. 1995;23:3794-3795.
31. Holt SE, Norton JC, Wright WE, et al. Comparison of the telomeric repeat amplification protocol (TRAP) to the new TRAP-eze telomerase detection kit. Meth Cell Sci. 1996;18:237-248.
32. Muller M, Krause H, Heicappell R, et al. Detection of human telomerase RNA (hTR) and telomerase activity in urine for diagnosis of bladder cancer. Clin Cancer Res. 1998;4:1949-1954.
33. Ohyashiki K, Ohyashiki JH, Nishimaki J, et al. Cytological detection of telomerase activity using an in situ telomeric repeat amplification protocol assay. Cancer Res. 1997;57:2100-2103.
34. Yashima K, Piatyszek MA, Saboorian HM, et al. Telomerase activity and in situ telomerase RNA expression in malignant and non-malignant lymph nodes. J Clin Pathol. 1997;50:110-117.
35. Sommerfeld HJ, Meeker AK, Piatyszek MA, et al. Telomerase activity: a prevalent marker of malignant human prostate tissue. Cancer Res. 1996;56:218-222.
36. Scates DK, Muir GH, Venitt S, et al. Detection of telomerase activity in human prostate: a diagnostic marker for prostatic cancer? Br J Urol. 1997;80:263-268.
37. Zhang W, Kapusta LR, Slingerland JM, et al. Telomerase activity in prostate cancer, prostatic intraepithelial neoplasia, and benign prostatic epithelium. Cancer Res. 1998;58:619-621.
38. Kallakury BVS, Brien TP, Lowry CV, et al. Telomerase activity in human benign prostate tissue and prostatic adenocarcinomas. Diagn Mol Pathol. 1997;6:192-198.
39. Lin Y, Uemura H, Fujinami K, et al. Telomerase activity in primary prostate cancer. J Urol. 1997;157:1161-1165.
40. Lin Y, Uemura H, Fujinami K, et al. Detection of telomerase activity in prostate needle-biopsy samples. Prostate. 1998;36:121-128.
41. Koeneman KS, Pan CX, Jin JK, et al. Telomerase activity, telomerase length, and DNA ploidy in prostatic intraepithelial neoplasia (PIN). J Urol. 1998;160:1533-1539.
42. Hiyama E, Gollahon L, Kataoka T, et al. Telomerase activity in human breast tumors. J Natl Cancer Inst. 1996;88:116-122.
43. Tsao JI, Zhao Y, Lukas J, et al. Telomerase activity in normal and neoplastic breast. Clin Cancer Res. 1997;3:627-631.
44. Sugino T, Yoshida K, Tahara H, et al. Telomerase activity in human breast cancer and benign breast lesions: diagnostic applications in clinical specimens, including fine needle aspirates. Int J Cancer. 1996;69:301-306.
45. Bednarek AK, Sahin A, Brenner AJ, et al. Analysis of telomerase activity levels in breast cancer: positive detection at the in situ breast carcinoma stage. Clin Cancer Res. 1997;3:11-16.
46. Nawaz S, Hashizumi TL, Markham NE, et al. Telomerase expression in human breast cancer with and without lymph node metastases. Am J Clin Pathol. 1997;107:542-547.
47. Clark GM, Osborne CK, Levitt D, et al. Telomerase activity and survival of patients with node-positive breast cancer. J Natl Cancer Inst. 1997;89:1874-1881.
48. Hoos A, Hepp HH, Kaul S, et al. Telomerase activity correlates with tumor aggressiveness and reflects therapy effect in breast cancer. Int J Cancer. 1998;79:8-12.
49. Ito H, Kyo S, Kanaya T, et al. Expression of human telomerase subunits and correlation with telomerase activity in urothelial cancer. Clin Cancer Res. 1998;4:1603-1608.
50. Lee DH, Yang SC, Hong SJ, et al. Telomerase: a potential marker of bladder transitional cell carcinoma in bladder washes. Cin Cancer Res. 1998;4:535-538.
51. Kyo S, Kunimi K, Uchibayashi T, et al. Telomerase activity in human urothelial tumors. Am J Clin Pathol. 1997;107:555-560.
52. Kinoshita H, Ogawa O, Kakehi Y, et al. Detection of telomerase activity in exfoliated cells in urine from patients with bladder cancer. J Natl Cancer Inst. 1997;89:724-730.
53. Rohde V, Sattler HP, Oehlenschlager B, et al. Genetic changes and telomerase activity in human renal cell carcinoma. Clin Cancer Res. 1998;4:197-202.
54. Mehle C, Piatyszek MA, Ljungberg B, et al. Telomerase activity in human renal cell carcinoma. Oncogene. 1996;13:161-166.
55. Kyo S, Takakura M, Tanaka M, et al. Telomerase activity in cervical cancer is quantitatively distinct from that in its precursor lesions. Int J Cancer. 1998;79:66-70.
56. Shroyer KR, Thompson LC, Enomoto T, et al. Telomerase expression in normal epithelium, reactive atypia, squamous dysplasia, and squamous cell carcinoma of the uterine cervix. Am J Clin Pathol. 1998;109:153-162.
57. Anderson S, Shera K, Ihle J, et al. Telomerase activation in cervical cancer. Am J Pathol. 1997;151:25-31.
58. Kyo S, Takakura M, Ishikawa H, et al. Application of telomerase assay for the screening of cervical lesions. Cancer Res. 1997;57:1863-1867.
59. Yashima K, Ashfaq R, Nowak J, et al. Telomerase activity and expression of its RNA component in cervical lesions. Cancer. 1998;82:1319-1327.
60. Yokoyama Y, Takahashi Y, Shinohara A, et al. Telomerase activity in the female reproductive tract and neoplasms. Gynecol Oncol. 1998;68:145-149.
61. Shroyer KR, Stephens JK, Silverberg SG, et al. Telomerase expression in normal endometrium, endometrial hyperplasia, and endometrial adenocarcinoma. Int J Gynecol Pathol. 1997;16:225-232.
62. Brien TP, Kallakury BVS, Lowry CV, et al. Telomerase activity in benign endometrium and endometrial carcinoma. Cancer Res. 1997;57:2760-2764.
63. Oishi T, Kigawa J, Minagawa Y, et al. Alteration of telomerase activity associated with development and extension of epithelial ovarian cancer. Obstet Gynecol. 1998;91:568-571.
64. Kyo S, Takakura M, Tanaka M, et al. Quantitative differences in telomerase activity among malignant, premalignant, and benign ovarian lesions. Clin Cancer Res. 1998;4:399-405.
65. Taharah H, Kuniyasu H, Yasui W, et al. Telomerase activity in gastric and colorectal carcinomas correlates well with malignant progression. Clin Cancer Res. 1995;1:1245-1251.
66. Chadeneau C, Hay K, Hirte HW, et al. Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res. 1995;55:2533-2536.
67. Li, ZH, Salovaara R, Aaltonen LA, et al. Telomerase activity is commonly detected in hereditary nonpolyposis colorectal cancer. Am J Pathol. 1996;148:1075-1079.
68. Yoshida K, Sugino T, Goodison S, et al. Detection of telomerase activity in exfoliated cancer cells in colonic luminal washings and its related clinical implications. Br J Cancer. 1997;75:548-553.
69. Brown T, Aldous W, Lance R, et al. The association between telomerase, p53, and clinical staging in colorectal cancer. Am J Surg. 1998;175:364-366.
70. Hiyama E, Yokoyama T, Tatsumoto N, et al. Telomerase activity in gastric cancer. Cancer Res. 1995;55:3258-3262.
71. Ahn MJ, Noh YH, Lee YS, et al. Telomerase activity and its clinicopathological significance in gastric cancer. Eur J Cancer. 1997;33:1309-1313.
72. Miura N, Horikawa I, Nishimoto A, et al. Progressive telomerase shortening and telomerase reactivation during hepatocellular carcinogenesis. Cancer Genet Cytogenet. 1997;93:56-62.
73. Tahara H, Nakanishi T, Kitamoto M, et al. Telomerase activity in human liver tissues: correlation between chronic liver disease and hepatocellular carcinoma. Cancer Res. 1995;55:2734-2736.
74. Nouso K, Urabe Y, Higashi T, et al. Telomerase as a tool for the differential diagnosis of human hepatocellular carcinoma. Cancer. 1996;78:232-236.
75. Nakashio R, Kitamoto M, Tahara H, et al. Significance of telomerase activity in the diagnosis of small differentiated hepatocellular carcinoma. Int J Cancer. 1997;74:141-147.
76. Hiyama E, Kodama T, Shinbara K, et al. Telomerase activity is detected in pancreatic cancer but not in benign tumors. Cancer Res. 1997;57:326-331.
77. Iwao T, Hiyama E, Yokoyama T, et al. Telomerase activity for the preoperative diagnosis of pancreatic cancer. J Natl Cancer Inst. 1997;89:1621-1623.
78. Hiyama K, Hiyama E, Ishioka S, et al. Telomerase activity in small-cell and non-small-cell lung cancers. J Natl Cancer Inst. 1995;87:895-902.
79. Yashima K, Litzky LA, Kaiser L, et al. Telomerase expression in respiratory epithelium during the multistage pathogenesis of lung carcinomas. Cancer Res. 1997;57:2373-2377.
80. Califano J, Ahrent S, Meininger G, et al. Detection of telomerase activity in oral rinses from head and neck squamous cell carcinoma patients. Cancer Res. 1996;56:5720-5722.
81. Hohaus S, Cavallo S, Bellacosa A, et al. Telomerase in human laryngeal squamous cell carcinoma. Clin Cancer Res. 1996;2:1895-1900.
82. Mao L, El-Naggar AK, Fan YH, et al. Telomerase activity in head and neck squamous cell carcinoma and adjacent tissues. Cancer Res. 1996;56:5600-5604.
83. Langford LA, Piatyszek MA, Xu R, et al. Telomerase activity in human brain tumours. Lancet. 1995;346:1267-1268.
84. DeMasters BKK, Markham N, Lillehei KO, et al. Differential telomerase expression in human primary intracranial tumors. Am J Clin Pathol. 1997;107:548-554.
85. Langford LA, Piatyszek MA, Xu R, et al. Telomerase activity in ordinary meningiomas predicts poor outcome. Hum Pathol. 1997;28:416-420.
86. Hiyama E, Hiyama K, Yokohama T, et al. Correlating telomerase activity levels with human neuroblastoma outcomes. Nature. Med 1995;1:249-255.
87. Gupta J, Han LP, Wang P, et al. Development of retinoblastoma in the absence of telomerase activity. J Natl Cancer Inst. 1996;88:1152-1157.
88. Kinoshita H, Ogawa O, Mishina M, et al. Telomerase activity in adrenal cortical tumors and pheochromocytomas with reference to clinicopathologic features. Urol Res. 1998;26:29-32.
89. Taylor RS, Ramirez RD, Ogoshi M, et al. Detection of telomerase activity in malignant and nonmalignant skin conditions. J Invest Dermatol. 1996;106:759-765.
90. Sakurai S, Fukayama M, Kaizaki Y, et al. Telomerase activity in gastrointestinal stromal tumors. Cancer. 1998;83:2060-2066.
91. Mu XC, Brien TP, Ross JS, et al. Telomerase activity in benign and malignant cytologie fluids. Cancer Cytopathol. In press.
92. Shay JW, Bacchetti S. A survey of telomerase activity in human cancer. Eur J Cancer. 1997;33:787-791.
93. Shay JW, Wright WE. Telomerase activity in human cancer. Curr Opin Oncol. 1996;8:66-71.
94. Bacchetti S, Counter CM. Telomeres and telomerase in human cancer. Int J Oncol. 1995;7:423-432.
95. Lundblad V, Wright WE. Telomeres and telomerase: a simple picture becomes complex. Cell. 1996;87:369-375.
96. Morin GB. Is telomerase a universal cancer target? J Natl Cancer Inst. 1995;87:859-861.
97. Battifora H. The telomerase story. No end in sight? (editorial). Am J Clin Pathol. 1997;107:505.
98. Shay JW, Gazdar AF. Telomerase in early detection of cancer. J Clin Pathol. 1997;50:106-109.
99. Melana SM, Holland JF, Pogo BG. Inhibition of cell growth and telomerase activity of breast cancer cells in vitro by 3′-azido-3′-deoxythymidine. Clin Cancer Res. 1998;4:693-696.
100. Naasani I, Seimiya H, Tsuruo T. Telomerase inhibition, telomere shortening, and senescence of cancer cells by tea catechins. Biochem Biophys Res Commun. 1998;249:391-396.
101. Shay JW. The regulation of telomerase in aging and cancer. Presented at the 4th Annual Meeting of the Association for Molecular Pathology, Crystal City, VA, November 5-8, 1998.